Ownership history in Frazier Life Sciences Management, L.P. · 15 quarters on record
This page tracks every 13F SEC filing in which Frazier Life Sciences Management, L.P. reported a position in SILENCE THERAPEUTICS PLC (SLN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 970,130 | — | 0% | 0.15% | $5.0M | $5.19 |
| 2025 Q2 | REDUCED | 970,130 | -178,461 | -15.5% | 0.23% | $5.6M | $5.80 |
| 2025 Q1 | UNCHANGED | 1,148,591 | — | 0% | 0.15% | $3.2M | $2.82 |
| 2024 Q4 | UNCHANGED | 1,148,591 | — | 0% | 0.33% | $7.9M | $6.88 |
| 2024 Q3 | UNCHANGED | 1,148,591 | — | 0% | 0.84% | $20.9M | $18.18 |
| 2024 Q2 | UNCHANGED | 1,148,591 | — | 0% | 1.02% | $21.8M | $19.00 |
| 2024 Q1 | ADDED | 1,148,591 | +267,418 | +30.3% | 1.05% | $24.8M | $21.60 |
| 2023 Q4 | UNCHANGED | 881,173 | — | 0% | 0.82% | $15.3M | $17.37 |
| 2023 Q3 | UNCHANGED | 881,173 | — | 0% | 0.58% | $8.7M | $9.82 |
| 2023 Q2 | UNCHANGED | 881,173 | — | 0% | 0.29% | $4.8M | $5.50 |
As of 2025 Q4 — sorted by position size